---
title: "Genprex, Inc. (GNPX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GNPX.US.md"
symbol: "GNPX.US"
name: "Genprex, Inc."
industry: "Biotechnology"
datetime: "2026-05-20T10:04:12.900Z"
locales:
  - [en](https://longbridge.com/en/quote/GNPX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GNPX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GNPX.US.md)
---

# Genprex, Inc. (GNPX.US)

## Company Overview

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company’s lead product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.genprex.com](https://www.genprex.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.49 | 134 | - | - | - |
| PB | 0.48 | 40 | 6.52 | 5.14 | 1.82 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2024-11-19T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.79 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/GNPX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/GNPX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/GNPX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/GNPX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**